1.
Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia
by Brownfoot, Fiona C
Hypertension (Dallas, Tex. 1979), 2015, Vol.66 (3), p.687-697
2.
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial)
by Jones, Peter H
The American journal of cardiology, 2003, Vol.92 (2), p.152-160
3.
Role of Complement Component C1q in the Onset of Preeclampsia in Mice
by Singh, Jameel
Hypertension (Dallas, Tex. 1979), 2011, Vol.58 (4), p.716-724
4.
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging
by Varela, Ignacio
Nature Medicine, 2008, Vol.14 (7), p.767-772
5.
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
by Nakamura, Haruo
The Lancet (British edition), 2006, Vol.368 (9542), p.1155-1163
6.
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
by Shepherd, James
The Lancet (British edition), 2002, Vol.360 (9346), p.1623-1630
7.
Pravastatin Attenuates Hypertension, Oxidative Stress, and Angiogenic Imbalance in Rat Model of Placental Ischemia-Induced Hypertension
by Bauer, Ashley J
Hypertension (Dallas, Tex. 1979), 2013, Vol.61 (5), p.1103-1110
8.
Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study
by Brouilette, Scott W, PhD
The Lancet (British edition), 2007, Vol.369 (9556), p.107-114
9.
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
by Sattar, Naveed, Prof
The Lancet (British edition), 2008, Vol.371 (9628), p.1927-1935
10.
Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis
by Nozue, Tsuyoshi, MD
The American heart journal, 2012, Vol.163 (2), p.191-199.e1
11.
Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin
by Lefkou, Eleftheria
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (5), p.e118
12.
Polymorphisms of the HNF1A Gene Encoding Hepatocyte Nuclear Factor-1α are Associated with C-Reactive Protein
by Reiner, Alexander P
American journal of human genetics, 2008, Vol.82 (5), p.1193-1201
13.
Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population
by van den Heuvel, D M J
Journal of neurology, neurosurgery and psychiatry, 2006, Vol.77 (2), p.149-153
14.
Usefulness of Statin Pretreatment to Prevent Contrast-Induced Nephropathy and to Improve Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention
by Patti, Giuseppe, MD
The American journal of cardiology, 2008, Vol.101 (3), p.279-285
15.
Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure
by Li, Feng
Acta pharmacologica Sinica, 2014, Vol.35 (6), p.792-805
16.
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial
by ASLANGUL, Elisabeth
AIDS (London), 2010, Vol.24 (1), p.77-83
17.
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation
by Logue, Jennifer
Heart (British Cardiac Society), 2011, Vol.97 (7), p.564-568
18.
Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospecti...
by Sponseller, Craig A., MD
Clinical therapeutics, 2014, Vol.36 (8), p.1211-1222
19.
Critical role of TNF inhibition in combination therapy for elderly mice with atherosclerosis
by Park, Kyung‐Yeon
Cardiovascular therapeutics, 2017, Vol.35 (6), p.e12280-n/a
20.
Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention
by Zhou, Zheng
The American heart journal, 2006, Vol.151 (2), p.273-281
